Interventional Oncology Devices – Market Insights – United States
The US market for interventional oncology devices will grow through 2032. This will be driven largely by the increasing shift toward higher-priced technologies, such as radioembolization, and expanding populations that are treatable with ablation.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2032.
The COVID-19 pandemic had short term consequences on the interventional oncology device market.
To what extent did COVID-19 affect the different procedure types in the interventional oncology device market?
How has recovery progressed in this space?
The adoption rates of different ablation modalities have shifted in recent years.
How will growth vary across different ablation device categories?
How strongly are cryoablation and IRE ablation being adopted?
What are the key ongoing clinical trials related to ablation, and what implications might they have on the interventional oncology device market?
Newer embolization technologies are seeing increasing adoption.
What is the adoption outlook for different embolization devices, and what factors will affect the uptake of these technologies over the forecast period?
What impact will clinical guidance have on the adoption of newer technologies in the embolization device market?
How will the adoption of radioembolization spheres be affected by recent clinical trials?
Table of contents
- Interventional Oncology Devices - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Interventional Oncology Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Interventional Oncology Procedures, by Procedure Type, US, 2019u20132032
- Interventional Oncology Procedures, by Indication, US, 2019u20132032
- Interventional Oncology Device Market, by Product Type, US (USD), 2019u20132032
- Interventional Oncology Device Market Growth, by Product Type, US, 2020u20132032
- Market Shares
- Competitive Insights
- Market Developments
- Ablation Device Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Ablation Procedures, by Indication, US, 2019u20132032
- Ablation Procedures, by Product Type, US, 2019u20132032
- Primary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Secondary Liver Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Kidney Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Lung Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Bone Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Pancreatic & Pelvic Cancer Ablation Procedures, by Procedure Type, US, 2019u20132032
- Ablation Disposables Market, by Product Type, US (USD), 2019u20132032
- Ablation Disposables Market Growth, by Product Type, US, 2020u20132032
- Ablation Capital Equipment Market, by Product Type, US (USD), 2019u20132032
- Ablation Capital Equipment Market Growth, by Product Type, US, 2020u20132032
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Irreversible Electroporation Ablation
- Market Shares
- Competitive Insights
- Embolization Particle Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Embolization Particle Procedures, by Indication, US, 2019u20132032
- Embolization Particle Procedures, by Product Type, US, 2019u20132032
- Primary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132032
- Secondary Liver Cancer Embolization Particle Procedures, by Procedures Type, US, 2019u20132032
- Kidney Cancer Embolization Particle Procedures, US, 2019u20132032
- Embolization Particle Market, by Product Type, US (USD), 2019u20132032
- Embolization Particle Market Growth, by Product Type, US, 2020u20132032
- PVA Particles
- Microspheres
- Drug-Eluting Beads
- Radioembolization Spheres
- Market Shares
- Competitive Insights
- Accessory Device Market
- Appendix
Raihan Jiwa is an analyst on the Cardiovascular Medtech Insights team at Clarivate. Raihan graduated from Western University with an Honors Specialization in Synthetic Biology. Raihan’s interest lies in the MedTech space as well as in the future of genetic engineering and development of healthcare systems in developing economies.